💊 ICIJ found in its yearlong project, "Cancer Calculus Investigation," involving 124 journalists across 37 countries, that pharmaceutical giant Merck's pricing and patent strategies for its cancer drug Keytruda drive up costs and limit patient access to the life-saving treatment.
Read how they worked on this project here ⬇️